London Pharmacy Oncology Education evening: “CAR-T Cell Therapy”

We are delighted to invite you to the next London Pharmacy Oncology Education evening on Wednesday 1st May, at the Royal Marsden Education & Conference centre, Stewart’s Grove, Chelsea, SW3 6JJ.
 
The aim of this meeting is to provide clinical and practice updates for all levels of pharmacists and technicians with an interest in oncology or haematology, as well as providing the perfect opportunity to share ideas and best practice.
 
At this “CAR-T Cell Therapy” meeting you will learn about:
 
 6.30pm Overiew of CAR-T Cell Therapy
Dr Emma Nicholson, Consultant Haematologist, The Royal Marsden NHS Foundation Trust
 
• 7pm Pharmacy Governance Issues & Commissioning, Patient Case Study
Nisha Shaunak , Lead Pharmacist for Oncology, Guy’s and St Thomas’ & Specialised Cancer Commissioning Pharmacist, NHS England (London region)
Jackie Chappell, Consultant Pharmacist, Haematology/ATMPs, King’s College Hospital NHS Foundation Trust
 
• 7.30pm Experience & Impact of first CAR-T trial patient
Annette Musallam, Lead Pharmacist Clinical Research & Development, The Royal Marsden NHS Foundation Trust
 
Refreshments and a light buffet will be provided from 6.00pm, in the conservatory area on the ground floor. The meeting will start at 6.30pm in the Julian Bloom Lecture Theatre, on the 1st floor. Please see the map included with this invitation, which shows the location of Royal Marsden Education & Conference centre.
 
Please register here https://www.eventbrite.com/e/london-pharmacy-oncology-education-evening-car-t-cell-therapy-tickets-57115627379 by Monday 22nd April, to enable us to plan effectively for this meeting.
 
If you register for this event and then find closer to the time that you cannot attend, please cancel your booking via the website or contact me directly ([email protected]).
 
Please pass on to all you colleagues who may be interested in attending and look forward to seeing you all there.
Best wishes
Anita
 
Anita McWhirter
New Models of Care Pharmacist
The Royal Marsden NHS Foundation Trust
 

Latest News

By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article
By BOPA IO SAG on 23rd April 2025

Toolkit for Immunotherapy IV to SC switch

Dear all, In the coming months, an increasing number of products traditionally administered intravenously are expected to become available for subcutaneous administration. This shift offers enhanced flexibility for patients; however,…

Read article
By BOPA E&T subcommittee on 17th April 2025

The BOPA Cancer Consultant Pharmacist Credentialing Support Series is back

BOPA are holding a nine month supportive webinar series for pharmacists who are credentialing as consultant pharmacists with the RPS. Join in this relaxed forum to discuss about your portfolio…

Read article
By BOPA research subcommittee on 17th April 2025

Celebration of BOPA member’s recent publications

We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then…

Read article